Titan Bio-Tech Ltd. (TITANBIO)
Market Closed
15 Oct, 10:00 PM
MSE MSE Primary ₹
400. 60
+0.65
+0.1625%
₹
17.18B Market Cap
17.48 P/E Ratio
8% Div Yield
14,449 Volume
0 Eps
₹ 399.95
Previous Close Want to track TITANBIO and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Upcoming TITANBIO split of 5:4 in 7 days (23 Oct 2026)
Summary
TITANBIO closed today higher at ₹400.6, an increase of 0.1625% from yesterday's close, completing a monthly increase of 3.7286% or ₹14.4. Over the past 12 months, TITANBIO stock lost -62.5257%.
TITANBIO pays dividends to its shareholders, with the most recent payment made on Sep 22, 2026. The next estimated payment will be in In 11 months on Sep 22, 2027 for a total of ₹0.5.
The last earnings report, released on May 28, 2026, exceeded the consensus estimates by 0%. On average, the company has surpassed earnings expectations by 6.5723%, based on the last three reports.
Titan Bio-Tech Ltd. has a scheduled stock split on Oct 23, 2026 for a 5:4 split ratio, meaning every TITANBIO investor will receive 5.0 shares for every 4.0 existing shares.
Titan Bio-Tech Ltd. has completed 2 stock splits, with the recent split occurring on Feb 20, 2026.
The company's stock is traded on one exchange.
TITANBIO Chart
People also search for
Titan Bio-Tech Ltd. (TITANBIO) FAQ
What is the stock price today?
The current price is ₹400.60.
On which exchange is it traded?
Titan Bio-Tech Ltd. is listed on MSE.
What is its stock symbol?
The ticker symbol is TITANBIO.
Does it pay dividends? What is the current yield?
Yes, It pays dividends and the current yield is 8%.
What is its market cap?
As of today, the market cap is 17.18B.
Has Titan Bio-Tech Ltd. ever had a stock split?
Titan Bio-Tech Ltd. had 2 splits and the recent split was on Feb 20, 2026.
Titan Bio-Tech Ltd. Profile
| Biotechnology Industry | Healthcare Sector | - CEO | MSE Exchange | INE150C01011 ISIN |
| India Country | 467 Employees | 22 Sep 2026 Last Dividend | 23 Oct 2026 Last Split | - IPO Date |
Titan Bio-Tech Ltd. operates as a notable entity in the biotechnology sector, primarily focusing on producing and marketing a diverse range of biological products. The company's portfolio includes enzymes, provitamins, and protein supplements, serving various industries such as pharmaceuticals, agriculture, and food processing. Titan Bio-Tech's commitment to quality and innovation ensures that its products align with industry standards and regulatory requirements, facilitating their wide acceptance and integration across targeted sectors. By leveraging cutting-edge biotechnological processes, Titan Bio-Tech enhances product efficiency and quality, catering to a broad customer base that includes healthcare facilities, educational institutions, and research organizations. As a key player in the biotechnology marketplace, Titan Bio-Tech contributes significantly to advancements in scientific research and industrial applications, playing a vital role in supporting the development of sustainable biological solutions that meet industry demands.
Contact Information
Address: 903-909, Bigjos Tower
Phone: 91 11 2735 5742
Website: https://titanbiotechltd.com
2026 © Marketlog. All Rights Reserved.
